A Phase IV, Single Center, Open-label, Single-arm Study to Evaluate the Efficacy and Safety of the Conversion to Tacrolimus Modified Release, ADVAGRAF After 12 Month Treatment With a Tacrolimus Stably in Liver Transplant Recipients.
Latest Information Update: 23 Nov 2021
At a glance
- Drugs Tacrolimus (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 11 Nov 2021 Results published in the Transplantation Proceedings
- 25 Feb 2021 New trial record